US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AnGes MG Inc.

0.3602

0.0000

Volume:- -

Turnover:- -

Market Cap:139.07M

PE:-0.68

High:0.3602

Open:0.3602

Low:0.3602

Close:0.3602

52wk High:0.3602

52wk Low:0.3602

Shares:386.08M

Float Shares:233.32M

Volume Ratio:3.25

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5300

EPS(LYR):-0.7603

ROE:-194.50%

ROA:-22.09%

PB:5.17

PE(LYR):-0.47

Loading ...

Overview Company News Filings

Company Profile

Company Name:

AnGes MG Inc.

Exchange:

EXPERT

Establishment Date:

1999

Employees:

55

Office Location:

Saito Bio-Incubator,1st Floor,7-7-15, Saito-asagi,Ibaraki,Osaka,Japan

Website:

http://www.anges-mg.com

Zip Code:

567-0085

Phone:

- -

Fax:

- -

Introduction:

AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte Growth Factor (HGF) Plasmid, a gene therapy for the treatment of ischemic diseases. The company is also developing NF-kB Decoy Oligonucleotide, a nucleic acid medicine that suppresses inflammation for diseases, including low back pain; drugs for treating atopic dermatitis and asthma; medical devices for the prevention of vascular medicine; cervical intraepithelial neoplasia therapeutic vaccines for cervical cancer; and DNA vaccines for high blood pressure through collaborative research agreement with Osaka University. The company was formerly known as AnGes MG, Inc. and changed its name to AnGes, Inc. in July 2017. AnGes, Inc. was incorporated in 1999 and is headquartered in Ibaraki, Japan.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AMGXF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AMGXF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMGXF\",,,,,undefined,":{"symbol":"AMGXF","market":"US","secType":"STK","nameCN":"AnGes MG Inc.","latestPrice":0.3602,"timestamp":1764968400000,"preClose":0.3602,"halted":0,"volume":0,"delay":15,"floatShares":233317811,"shares":386077320,"eps":-0.530016,"marketStatus":"Market Closed","change":0,"latestTime":"12-05 16:00:00 EST Delay","open":0.3602,"high":0.3602,"low":0.3602,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.530016,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.3602,"volumeRatio":3.253654977864523},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMGXF\",,,,,undefined,":{"symbol":"AMGXF","floatShares":233317811,"roa":"-22.09%","roe":"-194.50%","lyrEps":-0.760258,"volumeRatio":3.253654977864523,"shares":386077320,"dividePrice":0,"high":0.3602,"amplitude":0,"preClose":0.3602,"low":0.3602,"week52Low":0.3602,"pbRate":"5.17","psRate":"26.38","week52High":0.3602,"institutionHeld":0,"latestPrice":0.3602,"eps":-0.530016,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.530016,"open":0.3602,"prevYearClose":0.3602,"prevWeekClose":0.3602,"prevMonthClose":0.3602,"prevQuarterClose":0.3602,"fiveDayClose":0.3602,"twentyDayClose":0.3602,"sixtyDayClose":0.3602},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMGXF\",params:#limit:5,,,undefined,":[{"date":"2024-05-10","symbol":"AMGXF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715328000000,"name":null,"time":"","dateTimestamp":1715313600000,"actualEps":null},{"date":"2022-11-08","symbol":"AMGXF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1667898000000,"name":null,"time":"Pre-Market","dateTimestamp":1667883600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMGXF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMGXF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":8083355,"yearFounded":1999,"employeeNum":55,"address":"Saito Bio-Incubator,1st Floor,7-7-15, Saito-asagi,Ibaraki,Osaka,Japan","zipCode":"567-0085"},"stockCompanyDetail":{"websiteUrl":"http://www.anges-mg.com                           ","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"description":"AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte Growth Factor (HGF) Plasmid, a gene therapy for the treatment of ischemic diseases. The company is also developing NF-kB Decoy Oligonucleotide, a nucleic acid medicine that suppresses inflammation for diseases, including low back pain; drugs for treating atopic dermatitis and asthma; medical devices for the prevention of vascular medicine; cervical intraepithelial neoplasia therapeutic vaccines for cervical cancer; and DNA vaccines for high blood pressure through collaborative research agreement with Osaka University. The company was formerly known as AnGes MG, Inc. and changed its name to AnGes, Inc. in July 2017. AnGes, Inc. was incorporated in 1999 and is headquartered in Ibaraki, Japan.","exchange":"EXPERT","name":"AnGes MG Inc.","nameEN":"AnGes MG Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AMGXF\",market:\"US\",,,undefined,":null}}